Citigroup yesterday introduced a “poison pill” that discourages investors from buying more than 5 per cent of its shares and deters large shareholders from raising their stakes in an effort to protect a $43bn tax benefit.
花旗(Citigroup)昨日提出一項「毒丸計劃」，阻止投資者購買5%以上的股份，並阻止大股東增持股權，以此來保護430億美元的稅收優惠。
您已閱讀11%（290字），剩餘89%（2467字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。